异型慢性髓性白血病中CCND2突变:两例病例的报告
Giovanni Iaquinta1, Emilia Scalzulli2, Silvia Angeloni1
1U.O.C. Medical Genetics Laboratory, Department of Experimental Medicine, San Camillo-Forlanini Hospital - Sapienza University, Rome, Italy.
非典型慢性髓性白血病 (aCML) 可能具有CCND2突变,这在髓增殖性瘤中不常见. 这些突变可能表明aCML患者的疾病过程更为积极.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 非典型慢性髓性白血病 (aCML) 是一种罕见的骨髓显样/骨髓扩散性瘤 (MDS/MPN).
- aCML的定义是没有BCR::ABL1重组和常见的骨髓增殖性疾病突变.
- 在aCML中经常观察到SETBP1和ETNK1突变.
研究的目的:
- 为了研究CCND2突变在非典型慢性髓性白血病中的作用.
- 分析MDS/MPN患者中CCND2突变的临床意义.
- 为了确定攻击性aCML疾病的潜在标志物.
主要方法:
- 两名aCML患者的病例报告具有CCND2突变.
- 关于MPN和MDS/MPN中CCND2突变的文献综述.
- 分析突变状态和临床进展.
主要成果:
- 两例aCML病例在280和281号编码子中呈现了新的CCND2突变.
- 这些患者表现出疾病的快速进展.
- 文献综述表明,在MPN/MDS/MPN中很少检测到CCND2突变.
结论:
- CCND2突变可能与aCML的攻击性疾病有关.
- CCND2突变可以作为aCML的新预后标志物.
- 需要进一步的研究,以阐明CCND2在aCML病变发生中的作用.
更多相关视频
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
相关概念视频
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Differentiation of Common Myeloid Progenitor Cells
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancers Originate from Somatic Mutations in a Single Cell
